SCHEMBL6643293

SCHEMBL6643293

c1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(-c2cnco2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 12/20 0.64
EGFR P00533 3/20 0.53
CDK2 P24941 3/20 0.53
INSR P06213 2/20 0.53
MET P08581 2/20 0.53
KDR P35968 2/20 0.53
TEK Q02763 2/20 0.53
SYK P43405 2/20 0.45
FLT3 P36888 1/20 0.44
AURKA O14965 3/20 0.44
CHEK1 O14757 1/20 0.44
IKBKB O14920 1/20 0.44
NPC1 O15118 1/20 0.44
PDPK1 O15530 1/20 0.44
CHEK2 O96017 1/20 0.44
PRKCG P05129 1/20 0.44
CDK1 P06493 1/20 0.44
LYN P07948 1/20 0.44
MAPT P10636 1/20 0.44
KIT P10721 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17113389 0.77 SYK (0.52) EGFRSYKFLT3PRKCDBRAF
SCHEMBL4476385 0.77 SYK (0.52) EGFRSYKFLT3PRKCDBRAF
SCHEMBL6642791 0.76 IGF1R (0.71) IGF1REGFRCDK2INSRMET
SCHEMBL6319730 0.76 IGF1R (0.71) IGF1REGFRCDK2INSRMET
SCHEMBL1172781 0.75 PKMYT1 (0.64) IGF1REGFRCDK2INSRMET
SCHEMBL6312556 0.74 IGF1R (0.69) IGF1REGFRCDK2INSRMET
SCHEMBL6320480 0.74 IGF1R (0.69) IGF1REGFRCDK2INSRMET
SCHEMBL6318996 0.73 IGF1R (0.67) IGF1REGFRCDK2INSRMET
SCHEMBL1172597 0.73 SYK (0.43) EGFRCDK2SYKFLT3AURKA
SCHEMBL31592443 0.73 IGF1R (0.65) IGF1REGFRCDK2INSRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed